Schedule 13G ownership disclosure

BELLICUM PHARMACEUTICALS INC

Security class unavailable · CUSIP: 079481107

Event date: 2019-08-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-19-005539
Form type
SC 13G
Filer
ARMISTICE CAPITAL, LLC
CIK
CIK 1601086
Filed
Aug 26, 2019
Reporting period
Aug 16, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub